ENVALITH
日本農薬株式会社 logo

NIHON NOHYAKU CO.,LTD.

4997Prime MarketChemicals

日本農薬株式会社 logo
NIHON NOHYAKU CO.,LTD.4997
Reference Indicators

Market Cap

838¥100M

P/E (Forecast)

P/B

0.9x

Dividend Yield (Forecast)

3.72%

ROE

8.9%

EV/EBITDA

6.9x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
81,910102,090103,03399,966111,822
Cost of Sales
56,16471,52873,13266,74473,765
Gross Profit
25,74630,56229,90033,22138,056
SG&A Expenses
19,10321,82322,46224,64527,178
Operating Income
6,6428,7397,4388,57610,878
Non-operating Income
8922,4012,8264,2365,072
Non-operating Expenses
1,7663,3604,3315,7265,423
Ordinary Income
5,7687,7795,9327,08610,527
Extraordinary Income
24845192,142191
Extraordinary Losses
19887944,6721,250
Pre-tax Income
5,8187,7385,8584,5569,468
Income Taxes
1,1382,5901,2452,1292,590
Net Income
4,5024,4884,7772,3567,228
EBITDA
8,39110,6479,54010,85513,399
Gross Margin
31.4%29.9%29.0%33.2%34.0%
Operating Margin
8.1%8.6%7.2%8.6%9.7%
ROA
3.8%3.3%3.0%1.5%4.7%
ROE
7.1%6.6%6.4%3.0%8.9%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
農薬105,45510,66610.1%
農薬以外の化学品4,17376918.4%
その他2,19342919.6%